Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

First Trust NYSE Arca Biotechnology Index Fund

+ Add to Watchlist

FBT:US

119.6200 USD 3.1600 2.71%

As of 20:04:01 ET on 03/27/2015.

Snapshot for First Trust NYSE Arca Biotechnology Index Fund (FBT)

Open: 117.1700 High - Low: 120.0500 - 117.1700 Primary Exchange: NYSE Arca
Volume: 217,316 52-Week Range: 67.2700 - 128.1880 Beta vs BTK: 0.9989

ETF Chart for FBT

No chart data available.
  • FBT:US 119.6200
  • 1D
  • 1M
  • 1Y
116.4600
Interactive FBT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FBT

First Trust NYSE Arca Biotechnology Index Fund is an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to the price and yield of an equity index called the Amex Biotechnology Index.

Inception Date: 2006-06-23 Telephone: 1-630-765-8000
Managers: -
Web Site: www.ftportfolios.com

Fundamentals for FBT

NAV (on 2015-03-27) 119.5600
Assets (M) (on 2015-03-27) 3,180.2960
Shares out (M) 26.60
Market Cap (M) 3,181.89
% Premium 0.05
Average 52-Week % Premium 0.0268
Fund Leveraged N

Dividends for FBT

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2015-03-25) 0.0476
Dividend Yield (ttm) 0.08%

Performance for FBT

1-Month +3.85% 1-Year +54.69%
3-Month +15.72% 3-Year +43.45%
Year To Date +17.30% 5-Year +25.98%
Expense Ratio 0.60

Top Fund Holdings for FBT

Filing Date: 03/26/2015
Name Position Value % of Total
Intercept Pharmaceuticals Inc 632,329 178,753,085 5.767%
Pharmacyclics Inc 654,327 167,749,813 5.412%
Celldex Therapeutics Inc 4,692,838 121,826,074 3.930%
Biogen Inc 269,864 115,752,766 3.734%
Incyte Corp 1,281,115 114,275,458 3.687%
United Therapeutics Corp 675,238 113,115,870 3.649%
Medivation Inc 877,933 112,709,039 3.636%
BioMarin Pharmaceutical Inc 957,208 110,605,384 3.568%
Charles River Laboratories Int 1,396,684 110,352,003 3.560%
Seattle Genetics Inc 3,035,799 108,438,740 3.498%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil